CHA Medical & Bio Group Inaugurates Major Gene Biobank Facility

0

[Courtesy of CHA Medical & Bio Group]

SEOUL — CHA Medical & Bio Group, a South Korean medical group specializing in gene and biotherapy, will build a giant cell gene biobank facility, which will be the size of about ten football fields and will serve as the main Group research targeting Asian cell and biotherapy. gene therapy market.

The medical group has launched a $250 million project to build its Cell Gene Biobank (CGB) in Pangyo south of Seoul. Construction began on March 30 and will be completed in 2024. Technologies related to cell and gene therapies such as cell separation, cell culture and cryopreservation will be studied and developed at CGB, which has been described as one of the biggest in the world.

The facility will provide integrated contract development and manufacturing organization (CDMO) services for messenger RNA (mRNA), viral vectors and plasmid DNA, as well as a good manufacturing production system (GMP) with several separate clean rooms for greater efficiency.

mRNA is a transient intermediary between genes and proteins. It has emerged as a new class of therapeutic agent to prevent and treat various diseases. Plasmid DNA is gaining importance for clinical research applications in gene therapy and gene vaccination.
GMP is a system designed to ensure that a facility’s pharmaceutical production is managed and controlled to minimize manufacturing risks, maximize efficiency and quality of products or services.


“The development and production of cell and gene therapies requires deep expertise and highly specialized equipment compared to other biologics with more established manufacturing processes, such as antibodies,” said Cha Kwang-yul, chief from CHA Medical Group’s Global Research and Innovation Division, in a statement in March. 30.

“We believe this CGB will function as the leading cell and gene therapy manufacturing hub in Asia,” Cha said, emphasizing the importance of CGB and its role as a growth engine for the medical group.

The medical group specializes in the research, development and clinical trials of biotherapy and medicine, including cell and gene therapy technologies. The hospitals operated by the medical group are recognized as the best gynecology specialists in the country that offer infertility clinic service and high risk pregnancy care unit service.


© Aju Business Daily & www.ajunews.com Copyright: Nothing on this site may be reproduced, distributed, transmitted, displayed, published or broadcast without the permission of Aju News Corporation.

Share.

Comments are closed.